(Press-News.org) CLEVELAND—A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.
The team’s findings, recently published in the journal Nature Communications, may suggest a possible new treatment for excessive alcohol use—including alcohol-use disorder (AUD), a health condition that causes about 178,000 deaths in the United States each year, according to the Centers for Disease Control.
To date, the U.S. Food and Drug Administration (FDA) has approved only three medications to treat AUD.
The active ingredient in Wegovy and Ozempic is semaglutide, which belongs to a class of medications known as glucagon-like peptide-1 receptor agonists (GLP-1). GLP-1 helps regulate blood sugar in type 2 diabetes and reduces appetite.
The researchers examined electronic health records of nearly 84,000 patients with obesity. They found those treated with semaglutide, compared to those treated with other anti-obesity medications, showed a 50% to 56% decrease for both the initiation and re-occurrence of alcohol-use disorder in the year following.
“This is very promising news in that we may have a new therapeutic method to treat AUD,” said Rong Xu, a professor of biomedical informatics at the School of Medicine and the study’s lead researcher.
Xu, also director of the medical school’s Center for AI in Drug Discovery, was joined by medical school co-authors Nathan Berger, the Hanna-Payne Professor of Experimental Medicine, and Pamela Davis, the Arline H. and Curtis F. Garvin Research Professor. Nora D. Volkow, director of the National Institute for Drug Abuse, also co-authored the study.
“We collected real-world evidence in a manner similar to our previous two studies reported earlier this year,” Berger said. “In January we showed that semaglutide is associated with a decrease in suicidal thoughts, and in March, we demonstrated that semaglutide is also associated with a reduction in both new diagnoses and recurrence of cannabis-use disorder.”
Similar findings were replicated when the team examined electronic health records for about 600,000 patients with type 2 diabetes. Again, they found consistent reductions in alcohol-use disorder diagnoses among those treated with semaglutide.
“While the findings are promising and provide preliminary evidence of the potential benefit of semaglutide in AUD in real-world populations,” Davis said, “further randomized clinical trials are needed to support its use clinically for AUD.”
END
New study finds popular diabetes and weight-loss drugs associated with reduction in incidence and recurrence of alcohol-use disorder by at least half
2024-06-03
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Protein discovery could help prevent cancer treatment-related heart damage
2024-06-03
Blocking a protein known as CDK7 could prevent heart damage associated with a commonly used cancer chemotherapy medication, according to a study led by scientists at Washington State University. Importantly, the researchers also found that inhibiting CDK7 could help enhance the medication’s cancer-killing capability.
Based on an animal model, the study findings could provide a foundation for future treatment strategies to reduce chemotherapy-related heart toxicity and increase treatment effectiveness. ...
Fewer than 1 in 4 patients receive dietary counseling after a heart attack
2024-06-03
Although diet is the leading contributor to premature death from heart disease in the United States, fewer than one-quarter of people who undergo major heart events receive dietary counseling in the aftermath, a study finds.
The research, led by a team from the University of Michigan Health Frankel Cardiovascular Center, tracked nearly 150,000 patients seen at hospitals across Michigan for serious heart conditions — such as heart attack and heart failure — between late 2015 and early 2020.
Results published in Journal of the Academy of Nutrition ...
Endocrine Society Guideline recommends healthy adults under the age of 75 take the recommended daily allowance of vitamin D
2024-06-03
BOSTON—Healthy adults under the age of 75 are unlikely to benefit from taking more than the daily intake of vitamin D recommended by the Institutes of Medicine (IOM) and do not require testing for vitamin D levels, according to a new Clinical Practice Guideline issued today by the Endocrine Society. For children, pregnant people, adults older than 75 years and adults with high-risk prediabetes, the guideline recommends vitamin D higher than the IOM recommended daily allowance.
Vitamin D use and ...
A dark side to dark chocolate? New study finds very minimal risk for kids from metals in chocolates
2024-06-03
Chocolate lovers may have been alarmed by a 2023 Consumer Reports finding that some dark chocolate brands could contain harmful levels of lead and cadmium.
However, a new study by Tulane University published in Food Research International has found that dark chocolate poses no adverse risk for adults and contains nutritionally beneficial levels of essential minerals.
The study sampled 155 dark and milk chocolates from various global brands sold in the United States and tested for the presence of 16 heavy metals ranging from the toxic (lead and cadmium) to the essential (copper, iron, zinc). The study then modeled the risk of eating one ounce of the chocolates per day which ...
ECOG-ACRIN completes first trial of Black patients with early-stage breast cancer
2024-06-03
Black patients with early-stage breast cancer who were treated with docetaxel chemotherapy every 3 weeks had less drug-induced peripheral neuropathy and significantly fewer dose reductions compared to those who received weekly paclitaxel, according to a trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). Study EAZ171 is the first National Cancer Institute (NCI)-sponsored trial to focus specifically on enrolling a minority or underserved population to assess drug-induced toxicity (rather than drug efficacy) ...
Understanding the atomic density fluctuations in silica glass
2024-06-03
In materials science, particularly in the study of glasses, the intermediate range order (IRO) is one of the most intriguing research areas owing to its significant influence over the physical properties of glasses. The IRO refers to the structural arrangement of atoms beyond the short-range order (atomic arrangement within a few atomic distances) but shorter than the long-range order (arrangement patterns over macroscopic distances). Notably, for covalent glasses, the IRO is marked by atomic density fluctuations.
Scattering experiments provide a distinct signature of ...
Crucial shift in River Nile’s evolution during ancient Egypt discovered
2024-06-03
Crucial shift in River Nile’s evolution during ancient Egypt discovered
Researchers have explored how the River Nile evolved over the past 11,500 years and how changes in its geography could have helped shape the fortunes of ancient Egyptian civilisation.
Research published in Nature Geoscience reveals a major shift in the Nile around four thousand years ago, after which the floodplain in the Nile Valley around Luxor greatly expanded.
The findings raise the possibility that this shift could have contributed to the success of the ancient Egyptian agricultural economy at points between the Old and New Kingdom periods. ...
Study shows college students have less empathy when they are less alert
2024-06-03
DARIEN, IL – A new study to be presented at the SLEEP 2024 annual meeting found robust evidence that implicates lower alertness, a key outcome of insufficient sleep, as a predictor of muted empathic responding, which suggests alertness may support both cognitive and affective empathy.
Results show that slower response times on objective alertness tests were significantly associated with lower levels of empathic concern, and that lapses and false starts on these tests were significantly associated with poorer empathic accuracy. Additionally, those ...
Study finds that older adults with sleep apnea have higher odds of hospitalization
2024-06-03
DARIEN, IL – A new study to be presented at the SLEEP 2024 annual meeting found that sleep apnea is associated with increased odds of future utilization of health care services including hospitalization among older adults.
Results show that participants aged 50 years and older with sleep apnea had a 21% higher odds of reporting future use of any health service compared with those without sleep apnea. Specifically, individuals with sleep apnea had 21% higher odds of hospitalization after controlling for potential confounders including demographics, body mass index, health conditions, and depressive symptoms.
“Our research indicates that older adults who have sleep apnea are more ...
Most sleep tips shared on TikTok are supported by scientific evidence
2024-06-03
DARIEN, IL – A new study to be presented at the SLEEP 2024 annual meeting found that most sleep tips shared on TikTok are supported by empirical evidence.
The research findings show that of 35 unique sleep tips shared in popular videos, there was empirical support for 29. Only six sleep tips were unsupported by scientific evidence.
“These results suggest that the sleep research and sleep medicine communities have done a good job of promoting appropriate tips for sleep hygiene,” said lead author Brian T. Gillis, who has studied sleep for eight years and is an assistant professor of marriage and family therapy in the College of Human Sciences ...